Global Life Science Analytics Market Size Costs $ 14.15 Billion By 2028

Global Life Science Analytics Market Size Costs $ 14.15 Billion By 2028

Key Highlights of Life Science Analytics Market

The increasing popularity of analytics in life sciences has resulted in many new developments. For instance, in March 2021, Change Healthcare and Amazon Web Services (AWS) launched Data Science-as-a-Service (DSaaS) that is expected to enhance IT security in life science organizations. Cerner announced plans to acquire the health division of Kantar Group for USD 375 million in December 2020. Kantar Group is involved in providing data analytics to the life sciences industry.

Regional Developments

Please specify your research requirement and get a customized report @

Story Highlights

  • Request for A Sample Report:

  • In terms of type, the descriptive segment accounted for the higher share in the global market, on account of increasing demand for quantifiable and description analysis to gain an in-depth understanding of business scenarios. Industry participants can forecast opportunities and major trends with the help of these descriptive datasets.
    In terms of application, the sales and marketing support segment generated the largest revenue share, owing to the rise in the adoption of analytical solutions to boost overall sales productivity coupled with an increasing preference for post-marketing surveillance.
    Based on end-use, the pharmaceutical companies emerged as the most promising end-use segment and are expected to witness tremendous growth during the forecast period. The growing necessity to improve clinical trial efficiency and increasing demand for personalized medicine are boosting the segment’s growth.
    The outbreak of the COVID-19 pandemic is projected to positively impact the market globally as it has resulted in increased initiatives to develop new vaccines, drugs, and clinical trials are being conducted at large volumes across the world.

The North American region is taking the lead position in the life science analytics market in terms of higher revenue generation. The rising frequency of chronic diseases, the developing life sciences industry, the growing acceptance of new technologies for drug development, and the existence of established players in the region are all major factors driving regional market expansion. The Asia Pacific is projected to garner rapid growth as a result of the rising prevalence of chronic diseases, the growth of the life science industry, increasing adoption of advanced technologies, and the growing focus of major players on expanding their presence in emerging Asian countries.

Competitive Outlook

The life science analytics market is highly competitive, with a significant number of competitors targeting market share. Players emphasize the R&D programs, regional expansions, and strategic collaborations to gain positive momentum in the global market. Key Companies including : IBM, Accenture plc, Amazon Web Services, Inc., Allscripts Healthcare Solutions, Inc., Alteryx, Cerner Corporation, Cognizant, Cotiviti Holdings, Inc., IQVIA, MaxisIT Inc, Microsoft Corporation, Optum, Inc., Oracle Corporation, Pyramid Analytics, SAS Institute, SCIO Health Analytics (part of EXL Health), Sisense, Take Solutions Ltd., ThoughtSpot, Inc., Wipro Limited

Target Audience Supply Side: Analytics Software Developers
Demand Side: Medical Devices Industry, Pharmaceutical Sector
Regulatory Side: World Health Organization

Have Any Query Or Specific Requirement? Feel Free to Ask Our Industry Experts at: Polaris Market research has segmented the life science analytics market report on the basis of type, component, application, delivery, end-use, and region:

Life Science Analytics, Component Outlook (Revenue – USD Million, 2016 – 2028) Life Science Analytics, Application Outlook (Revenue – USD Million, 2016 – 2028)

Prescriptive Life Science Analytics, Type Outlook (Revenue – USD Million, 2016 – 2028)